Drug retention and distribution after intratumoral chemotherapy with fluorouracil/epinephrine injectable gel in human pancreatic cancer xenografts

Cancer Chemotherapy and Pharmacology

Volumn 44, Issue 4, 1999, Pages 267-274

  Smith, Jill P ^a,b   Kanekal, Sarathchandra ^b   Patawaran, Montesa B ^b   Chen, Joy Y ^b   Jones, Richard E ^b   Orenberg, Elaine K ^b   Yu, Ning Y ^b  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b Matrix Pharmaceutical Inc   (United States)

Author keywords

5 Fluorouracil epinephrine injectable gel; Pancreatic cancer; Sustained retention drug delivery

Indexed keywords

ADRENALIN; COLLAGEN GEL; FLUOROURACIL; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; AUTORADIOGRAPHY; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG LIVER LEVEL; DRUG RETENTION; GEL; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; INTRATUMORAL DRUG ADMINISTRATION; KIDNEY; LIQUID SCINTILLATION COUNTING; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PANCREAS CANCER; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; AUTORADIOGRAPHY; EPINEPHRINE; FLUOROURACIL; GELS; HUMANS; INJECTIONS, INTRALESIONAL; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PANCREATIC NEOPLASMS; SCINTILLATION COUNTING; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; VEHICLES;

EID: 0032779478     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050977     Document Type: Article

References (34)

1. Beck A, Etienne MC, Cheradame S, Fischel JL, Formento P, Renee N, Milano G (1994) A role of dihydropyrimidine dehydrogenase and thymidylate synthase in tumor sensitivity to fluorouracil. Eur J Cancer 30A: 1517
2. Brawer MK, Ploch NR, Narayan P, Anderson RU, Albert E, Romas N, Lerner S, Korey A, Baughman J (1994) Intralesional administration of fluorouracil therapeutic implant (MPI 5011) in patients with prostatic cancer. Proc Am Soc Clin Oncol 13: 246
3. Brennan MF, Kinsella TJ, Casper ES (1993) Cancer of the pancreas. In: DeVita TJ Jr, Hellman S, Rosenberg S (eds) Principles and practices of oncology, 4th edn. JB Lippincott, Philadelphia, pp 800-835
4. Burris HA III, Vogel CL, Castro D, Mishra L, Schwarz M, Spencer S, Oakes DD, Korey A, Orenberg EK (1998) Intratumoral cisplatin/epinephrine-injectable gel as a palliative treatment for accessible solid tumors: a multicenter pilot study. Otolaryngol Head Neck Surg 118: 496
5. Calabro-Jones PM, Byfield JE, Ward JF, Sharp TR (1982) Time-dose response relationships for 5-fluorouracil cytotoxicity against human epithelial cancer cells in vitro. Cancer Res 42: 4413
6. Caletti G, Ferrari A (1996) Endoscopic ultrasonography. Endoscopy 28: 156
7. Carter SK, Comis RL (1975) The integration of chemotherapy into a combined modality approved for cancer treatment: VI. pancreatic adenocarcinoma. Cancer Treat Rev 2: 193
8. Chang KJ, Albers CG, Erickson RA, Butler JA, Wuerker RB, Lin F (1994) Endoscopic ultrasound-guided fine needle aspiration of pancreatic carcinoma. Am J Gastroenterol 89: 263
9. Cullinan S, Moertel CG, Wieand HS, Shutt AJ, Krook JE, Foley JF, Norris BD, Kardinal CG, Tschetter LK, Barlow JI (1990) A phase III trial on the therapy of advanced pancreatic carcinoma: evaluations of the Mallison regimen and 5-fluorouracil, doxorubicin, and cisplatin. Cancer 65: 2207
10. Curley SA, Carrasco CH, Charnsangavej C, Siddak Z, Korey A (1994) Phase I trial of intratumoral cisplatin therapeutic implant (MPI 5010) in patients with primary or metastatic cancer of the liver. Proc Am Soc Clin Oncol 13: 403
11. Gudjonsson B (1987) Cancer of the pancreas: 50 years of surgery. Cancer 60: 2284
12. Hansen R, Quebbeman E, Ritch P, Chitamar C, Anderson T (1988) Continuous 5-fluorouracil infusion in carcinoman of the pancreas. Am J Med Sci 295: 91
13. Ishii H, Okada S, Tokuuye K, Nose H, Okusaka T, Yoshimori M, Nagahama H, Sumi M, Kagami Y, Ikeda H (1997) Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic adenocarcinoma. Cancer 79: 1516
14. Kanekal S, Sahai A, Jones RE, Brown D (1995) Storage- phosphor autoradiography: a rapid and highly sensitive method for spatial imaging and quantitation of radioisotopes. J Pharmacol Toxicol Methods 33: 171
15. Kelsen D, Hudis C, Niedzwiecki D, Dougherty J, Casper E, Botet J, Vinciguerra V, Rosenbluth R (1991) A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinosine, and caffeine in patients with advanced pancreatic carcinoma. Cancer 68: 965
16. Kitchell BE, Brown DM, Luck EE, Woods L, Orenberg EK, Bloch DA (1994) Intralesional implant for treatment of primary oral malignant melanoma in dogs. J Am Vet Med Assoc 204: 229
17. Kovach JS, Moertel CG, Schutt AJ, Hahn RG, Reitemeier RJ (1974) A controlled study of combined 1,3-bis(2-chloroethyl)- 1-nitrosourea and 5-fluorouracil therapy for advanced gastric and pancreatic cancer. Cancer 33: 563
18. Kraus S, Miller BH, Swinehart J, Shavin JS, Georgouras K, Jenner D, Griffin E, Korey A, Orenberg EK (1998) Intratumoral chemotherapy with fluorouracil/epinephrine injectable gel: A nonsurgical treatment of cutaneous squamous cell carcinoma. J Am Acad Dermatol 38: 438
19. MacMillan WE, Wolberg WH, Welling PG (1978) Pharmacokinetics of fluorouracil in humans. Cancer Res 38: 3479
20. Matsuno S, Hisano H, Kobari M, Akaishi S (1990) Growth- inhibitory effects of combination chemotherapy for human pancreatic cancer cell lines. Cancer 66: 2369
21. Miller BH, Shavin JS, Cognetta A, Taylor JR, Salasche S, Korey A, Orenberg EK (1997) Nonsurgical treatment approach for basal cell carcinomas with intralesional fluorouracil/epinephrine injectable gel. J Am Acad Dermatol 36: 72
22. Mishra L, Reilly J, Reilly H, Rofail M, Peters B, Kozam ML, Wadleigh R (1995) Treatment of esophageal cancer with endoscopic injection of methotrexate and cisplatin therapeutic gels. Gastroenterology 108: 168
23. Naguib FNM, el Kouni MH, Cha S (1985) Enzymes of uracil catabolism in normal and neoplastic human tissues. Cancer Res 45: 5405
24. Orenberg EK, Luck EE, Brown DM, Kitchell BE (1992) Implant delivery system. Intralesional delivery of chemotherapeutic agents for treatment of spontaneous skin tumors in veterinary patients. Clin Dermatol 9: 561
25. Parker SI, Tong T, Bolden S, Wingo PA (1996) Cancer statistics 1996. CA Cancer J Clin 46: 5
26. Sawabe Y, Yamagishi H, Yamaguchi N, Yamamura V, Oka T (1996) In vitro chemosensitivity of human pancreatic cancer cell lines. Int J Pancreat 20: 185
27. Smith FP, Hoth DV, Levin B, Karlin DA, MacDonald JS, Wooley PV III, Schein PS (1980) 5-fluorouracil, adriamycin and mitomycin C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas. Cancer 46: 2014
28. Smith JP, Stock E, Orenberg EK, Yu NY, Kanekal S, Brown DM (1995) Intratumoral chemotherapy with a sustained-release drug delivery system inhibits growth of human pancreatic cancer xenografts. Anticancer Drugs 6: 717
29. Tan MH, Nowak NJ, Loor R, Ochi H, Sandberg AA, Lopez C, Pickren JW, Berjian R, Douglass HO Jr, Chu TM (1986) Characterization of a new primary human pancreatic tumor line. Cancer Invest 4: 15
30. Whittington R, Neuberg D, Tester WJ, Benson AB III, Haller HG (1995) Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: a phase I Eastern Cooperative Oncology Group trial. J Clin Oncol 13: 227
31. Wiggans RG, Woolley PV III, MacDonald JS, Smythe T, Ueno W, Schein PS (1978) Phase II trial of streptozocin, mitomycin C and 5-fluorouracil (SMF) in the treatment of advanced pancreatic cancer. Cancer 41: 387
32. Wils JA (1991) Chemotherapy in pancreatic cancer: a rational pursuit? Anticancer Drugs 2: 3
33. World Health Organization (1997) The World Health Report. Geneva
34. Yu N, Orenberg EK, Luck EE, Brown DM (1995) Antitumor effect of intratumoral administration of fluorouracil/epinephrine injectable gel in C3H mice. Cancer Chemother Pharmacol 36: 27